Figure 2A shows the mutations of high‐confident NSCLC driver genes at the baseline of these 12 patients, reported by TCGA (The Cancer Genome Atlas).30, 31 Among these driver gene mutations, TP53 and CDKN2A were the most frequently mutated with frequencies of about 75% and 25%, respectively. This evidence concerns the gene TP53 and non-small cell lung carcinoma.